Mark Vogel
About Mark Vogel
Mark Vogel is the Director of Medical Communications/CV Publications for Mavacamten at Bristol Myers Squibb, with extensive experience in medical writing and communications, particularly in infectious diseases and cardiovascular publications.
Title
Mark Vogel is the Director of Medical Communications and CV Publications for Mavacamten (Worldwide Cardiovascular Publications) at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Mark Vogel currently oversees medical communications and cardiovascular publications for Mavacamten at Bristol Myers Squibb. His responsibilities include the strategic planning and execution of medical publications on a global scale. He engages with healthcare providers to ensure the dissemination of accurate and effective medical information related to cardiovascular diseases.
Previous Experience at MyoKardia
Before his current role, Mark Vogel worked at MyoKardia as a Manager of Medical Communications. During his tenure from 2019 to 2020, he was involved in various medical communication projects. The company, which was later acquired by BMS, provided him with critical experience in the cardiovascular sector.
Extensive Experience as a Medical Writer
Mark Vogel has extensive experience as a medical writer, having worked in various capacities including Senior Medical Writer at Mark Vogel Communications and Prime Global. He has created scientific publications such as white papers, presentations, manuscripts, posters, and abstracts. His role often involved delivering well-written copy with meticulous referencing, serving both consultative and strategic functions in project execution.
Board and Volunteer Work
Mark Vogel served on the Board of Directors for the STOP AIDS Project, where he also held the position of Vice President from 2007 to 2009. He has over a decade of research and writing experience focused on infectious diseases, particularly HIV, and contributed to public health initiatives in this area.
Educational Background
Mark Vogel holds a B.A. in English from San Jose State University and an M.A. in English from the University of Maryland. His academic background provided a strong foundation for his career in medical communications and scientific writing.